VA's Pharmacy Prime Vendor contract awarded to McKesson Corporation for $35.6M in FY2014
Contract Overview
Contract Amount: $35,618,638 ($35.6M)
Contractor: Mckesson Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2014-09-01
End Date: 2014-09-30
Contract Duration: 29 days
Daily Burn Rate: $1.2M/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 5
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2014 SEP
Place of Performance
Location: BAY PINES, PINELLAS County, FLORIDA, 33744
State: Florida Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $35.6 million to MCKESSON CORPORATION for work described as: EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2014 SEP Key points: 1. The contract value of $35.6M for a single month indicates significant pharmaceutical spending. 2. McKesson Corporation is a major player in the pharmaceutical distribution market. 3. The contract was awarded under full and open competition, suggesting a competitive bidding process. 4. The fixed-price contract type helps control costs for the VA.
Value Assessment
Rating: good
The contract's firm fixed price structure is standard for pharmaceutical procurement. Benchmarking against similar large-scale pharmaceutical contracts would be necessary for a precise value assessment, but the monthly value suggests substantial volume.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Awarded under full and open competition, this method typically drives competitive pricing. The VA likely received multiple bids, leading to a price discovery process that benefits taxpayers.
Taxpayer Impact: The competitive nature of the award is expected to yield favorable pricing for the VA, thus benefiting taxpayers through efficient use of funds.
Public Impact
Ensures timely access to essential pharmaceuticals for veterans. Supports the operational needs of VA healthcare facilities nationwide. Contributes to the stability of the pharmaceutical supply chain for a critical government agency.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Short contract duration (29 days) may indicate a bridge contract or a specific short-term need.
- Lack of specific product details makes it difficult to assess unit price efficiency.
- Potential for price fluctuations if this is a recurring short-term award.
Positive Signals
- Awarded under full and open competition.
- Firm fixed price contract type.
- Significant value suggests a critical need being met.
Sector Analysis
This contract falls within the healthcare sector, specifically pharmaceutical procurement. Benchmarks for similar large-scale pharmaceutical distribution contracts would typically be in the tens to hundreds of millions annually, depending on scope and duration.
Small Business Impact
This contract does not appear to have specific provisions for small business participation mentioned in the provided data. Large prime vendor contracts often involve complex supply chains where subcontracting opportunities for small businesses may exist but are not explicitly detailed here.
Oversight & Accountability
The Department of Veterans Affairs is responsible for oversight. The firm fixed price contract type provides a degree of cost control. Further oversight would involve monitoring delivery performance and adherence to contract terms.
Related Government Programs
- Pharmaceutical Preparation Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Short contract duration.
- Single vendor reliance.
- Lack of detailed performance metrics.
- Potential for price escalation in subsequent awards.
Tags
pharmaceutical-preparation-manufacturing, department-of-veterans-affairs, fl, delivery-order, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $35.6 million to MCKESSON CORPORATION. EXPRESS REPORT PHARMACY PRIME VENDOR (PPV) FY2014 SEP
Who is the contractor on this award?
The obligated recipient is MCKESSON CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $35.6 million.
What is the period of performance?
Start: 2014-09-01. End: 2014-09-30.
What is the typical duration and value of the Pharmacy Prime Vendor contract, and how does this specific award compare?
The provided data indicates a contract duration of 29 days and a value of $35.6 million for September 2014. Without historical data or information on the standard PPV contract structure, it's difficult to definitively compare. However, a $35.6 million monthly spend suggests a substantial, potentially recurring, requirement for pharmaceutical supplies.
What are the key performance indicators (KPIs) used to measure the success of this contract, and how was McKesson Corporation evaluated?
The provided data does not detail specific Key Performance Indicators (KPIs) or the evaluation criteria used for McKesson Corporation. Typically, for pharmaceutical prime vendor contracts, KPIs would include on-time delivery rates, order accuracy, product availability, and potentially price competitiveness over time. The VA would monitor these metrics to ensure contract compliance and effectiveness.
Are there any identified risks associated with relying on a single vendor like McKesson Corporation for such a critical supply chain function?
While awarded under full and open competition, reliance on a single vendor, even for a defined period, carries inherent risks. These include potential supply chain disruptions due to unforeseen events affecting McKesson, limited leverage for price renegotiation if the contract is extended, and the risk of vendor lock-in. The short duration mitigates some long-term risks.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Offers Received: 5
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: ONE POST ST, SAN FRANCISCO, CA, 94104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $35,618,638
Exercised Options: $35,618,638
Current Obligation: $35,618,638
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: VA797P12D0001
IDV Type: IDC
Timeline
Start Date: 2014-09-01
Current End Date: 2014-09-30
Potential End Date: 2014-09-30 00:00:00
Last Modified: 2019-08-20
More Contracts from Mckesson Corporation
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 November — $1.4B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 October — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 September — $1.2B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2025 July — $1.1B (Department of Veterans Affairs)
- Express Report: Pharmaceutical Prime Vendor (ppv)fy2026 December — $1.1B (Department of Veterans Affairs)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)